Header Logo

Connection

DAVID ROWLEY to Animals

Back to Details
This is a "connection" page, showing publications DAVID ROWLEY has written about Animals.
DAVID ROWLEY
Connection Strength
0.535
Animals
  1. RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation. Proc Natl Acad Sci U S A. 2014 Nov 18; 111(46):16389-94.
    View in: PubMed
    Score: 0.027
  2. WFDC1 is a key modulator of inflammatory and wound repair responses. Am J Pathol. 2014 Nov; 184(11):2951-64.
    View in: PubMed
    Score: 0.026
  3. Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis. Am J Pathol. 2014 Jun; 184(6):1860-70.
    View in: PubMed
    Score: 0.026
  4. FGFR1 is essential for prostate cancer progression and metastasis. Cancer Res. 2013 Jun 15; 73(12):3716-24.
    View in: PubMed
    Score: 0.024
  5. The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer. 2012 Dec; 19(6):R187-204.
    View in: PubMed
    Score: 0.023
  6. TGF-?1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One. 2010 Oct 29; 5(10):e13751.
    View in: PubMed
    Score: 0.020
  7. Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model. Prostate. 2009 Mar 01; 69(4):373-84.
    View in: PubMed
    Score: 0.018
  8. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7593-603.
    View in: PubMed
    Score: 0.018
  9. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Oncogene. 2008 Jan 17; 27(4):450-9.
    View in: PubMed
    Score: 0.016
  10. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005 Oct 01; 65(19):8887-95.
    View in: PubMed
    Score: 0.014
  11. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1. Prostate. 2004 Feb 15; 58(3):299-307.
    View in: PubMed
    Score: 0.013
  12. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. Cancer Res. 2003 Sep 15; 63(18):5859-65.
    View in: PubMed
    Score: 0.012
  13. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res. 2002 Nov 01; 62(21):6021-5.
    View in: PubMed
    Score: 0.012
  14. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res. 2002 Jun 01; 62(11):3298-307.
    View in: PubMed
    Score: 0.011
  15. In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate. 2001 Nov 01; 49(3):213-23.
    View in: PubMed
    Score: 0.011
  16. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT. J Clin Invest. 2021 02 15; 131(4).
    View in: PubMed
    Score: 0.010
  17. IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells. PLoS One. 2020; 15(12):e0244587.
    View in: PubMed
    Score: 0.010
  18. Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific. Oncogene. 2021 01; 40(3):693-704.
    View in: PubMed
    Score: 0.010
  19. The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers. Mamm Genome. 2000 Sep; 11(9):767-73.
    View in: PubMed
    Score: 0.010
  20. UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression. Oncogene. 2020 04; 39(15):3089-3101.
    View in: PubMed
    Score: 0.009
  21. Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung. Nat Commun. 2019 05 13; 10(1):2131.
    View in: PubMed
    Score: 0.009
  22. The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability. Cancer Cell. 2018 11 12; 34(5):823-839.e7.
    View in: PubMed
    Score: 0.009
  23. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells. Endocrinology. 1998 Aug; 139(8):3569-77.
    View in: PubMed
    Score: 0.009
  24. B lymphocytes secreting IgG linked to latent transforming growth factor-beta prevent primary cytolytic T lymphocyte responses. Int Immunol. 1998 Mar; 10(3):355-63.
    View in: PubMed
    Score: 0.008
  25. Molecular cloning and expression of ps20 growth inhibitor. A novel WAP-type "four-disulfide core" domain protein expressed in smooth muscle. J Biol Chem. 1998 Feb 20; 273(8):4574-84.
    View in: PubMed
    Score: 0.008
  26. What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev. 1998-1999; 17(4):411-9.
    View in: PubMed
    Score: 0.008
  27. Influence of the neural microenvironment on prostate cancer. Prostate. 2018 Feb; 78(2):128-139.
    View in: PubMed
    Score: 0.008
  28. Tenascin-C and Integrin a9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment. Cancer Res. 2017 11 01; 77(21):5977-5988.
    View in: PubMed
    Score: 0.008
  29. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG. Oncotarget. 2017 Jul 04; 8(27):44447-44464.
    View in: PubMed
    Score: 0.008
  30. A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis. Neoplasia. 2017 May; 19(5):421-428.
    View in: PubMed
    Score: 0.008
  31. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer. Oncogene. 2017 02 02; 36(5):618-627.
    View in: PubMed
    Score: 0.007
  32. Androgen-regulated proliferation and gene transcription in a prostate smooth muscle cell line (PS-1). Endocrinology. 1996 Mar; 137(3):864-72.
    View in: PubMed
    Score: 0.007
  33. Purification of a novel protein (ps20) from urogenital sinus mesenchymal cells with growth inhibitory properties in vitro. J Biol Chem. 1995 Sep 15; 270(37):22058-65.
    View in: PubMed
    Score: 0.007
  34. Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences. Prostate. 2015 Oct; 75(14):1643-61.
    View in: PubMed
    Score: 0.007
  35. FGFR1-WNT-TGF-? signaling in prostate cancer mouse models recapitulates human reactive stroma. Cancer Res. 2014 Jan 15; 74(2):609-20.
    View in: PubMed
    Score: 0.006
  36. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo. Clin Cancer Res. 2014 Jan 01; 20(1):100-9.
    View in: PubMed
    Score: 0.006
  37. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med. 1993 Sep 01; 178(3):841-52.
    View in: PubMed
    Score: 0.006
  38. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. Mol Ther. 2013 Aug; 21(8):1611-20.
    View in: PubMed
    Score: 0.006
  39. WFDC1/ps20: a host factor that influences the neutrophil response to murine hepatitis virus (MHV) 1 infection. Antiviral Res. 2012 Nov; 96(2):158-68.
    View in: PubMed
    Score: 0.006
  40. Glucocorticoid regulation of transforming growth factor-beta activation in urogenital sinus mesenchymal cells. Endocrinology. 1992 Jul; 131(1):471-8.
    View in: PubMed
    Score: 0.006
  41. Characterization of a fetal urogenital sinus mesenchymal cell line U4F: secretion of a negative growth regulatory activity. In Vitro Cell Dev Biol. 1992 Jan; 28A(1):29-38.
    View in: PubMed
    Score: 0.005
  42. A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci U S A. 1990 Feb; 87(4):1486-90.
    View in: PubMed
    Score: 0.005
  43. Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate. Cancer Res. 2008 Jul 01; 68(13):5143-51.
    View in: PubMed
    Score: 0.004
  44. Responses of NBT-II bladder carcinoma cells to conditioned medium from normal fetal urogenital sinus. Cancer Res. 1987 Jun 01; 47(11):2955-60.
    View in: PubMed
    Score: 0.004
  45. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Hum Pathol. 2007 Feb; 38(2):299-307.
    View in: PubMed
    Score: 0.004
  46. Properties of an intermediate-sized androgen receptor: association with RNA. Biochemistry. 1986 Nov 04; 25(22):6988-95.
    View in: PubMed
    Score: 0.004
  47. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res. 2006 May 15; 66(10):5159-64.
    View in: PubMed
    Score: 0.004
  48. Bystin in perineural invasion of prostate cancer. Prostate. 2006 Feb 15; 66(3):266-72.
    View in: PubMed
    Score: 0.004
  49. Effects of sodium molybdate on the androgen receptor from the R3327 prostatic tumor. Endocrinology. 1984 May; 114(5):1776-83.
    View in: PubMed
    Score: 0.003
  50. Molecular properties of the androgen receptor in rat ventral prostate. Ann N Y Acad Sci. 1984; 438:39-53.
    View in: PubMed
    Score: 0.003
  51. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma. Prostate. 1984; 5(1):101-11.
    View in: PubMed
    Score: 0.003
  52. Neuroepithelial interactions in prostate cancer are enhanced in the presence ofprostatic stroma. Urology. 2003 Apr; 61(4):870-5.
    View in: PubMed
    Score: 0.003
  53. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer. Mol Ther. 2000 Sep; 2(3):211-7.
    View in: PubMed
    Score: 0.002
  54. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter. Anticancer Res. 2000 Sep-Oct; 20(5A):2811-6.
    View in: PubMed
    Score: 0.002
  55. Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer. Anticancer Res. 2000 May-Jun; 20(3A):1359-65.
    View in: PubMed
    Score: 0.002
  56. Adenovirus-mediated suicide gene therapy for experimental bladder cancer. Urology. 1997 Feb; 49(2):173-80.
    View in: PubMed
    Score: 0.002
  57. Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med. 1992 Jan 01; 175(1):139-46.
    View in: PubMed
    Score: 0.001
  58. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance. Cancer Res. 1990 Jul 01; 50(13):3851-8.
    View in: PubMed
    Score: 0.001
  59. Monoclonal antibodies against the androgen receptor: recognition of human and other mammalian androgen receptors. Endocrinology. 1988 Jul; 123(1):601-10.
    View in: PubMed
    Score: 0.001
  60. A common molecular weight of the androgen receptor monomer in different target tissues. Biochemistry. 1987 Jun 02; 26(11):3174-82.
    View in: PubMed
    Score: 0.001
  61. Characterization of steroid receptors in human prostate using mibolerone. Prostate. 1986; 8(3):241-53.
    View in: PubMed
    Score: 0.001
  62. Structure and biochemistry of the Sertoli cell. Int Rev Cytol. 1985; 94:127-49.
    View in: PubMed
    Score: 0.001
  63. Exchange assay for androgen receptors in the presence of molybdate. J Steroid Biochem. 1984 Oct; 21(4):353-9.
    View in: PubMed
    Score: 0.001
  64. Affinity labeling of the androgen receptor in rat prostate cytosol with 17 beta-[(bromoacetyl)oxy]-5 alpha-androstan-3-one. Biochemistry. 1984 May 22; 23(11):2527-33.
    View in: PubMed
    Score: 0.001
  65. Purification and characterization of the androgen receptor from rat ventral prostate. Biochemistry. 1983 Dec 20; 22(26):6170-5.
    View in: PubMed
    Score: 0.001
  66. Purification and characterization of androgen receptor from steer seminal vesicle. Biochemistry. 1982 Aug 17; 21(17):4102-9.
    View in: PubMed
    Score: 0.001
  67. Production and characterization of an antibody to myosin light chain kinase and intracellular localization of the enzyme. Cell. 1981 Dec; 27(3 Pt 2):449-58.
    View in: PubMed
    Score: 0.001
  68. Effects of estrogen upon the fine structure of epithelium and stroma in the rat ventral prostate gland. Invest Urol. 1979 Jul; 17(1):83-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.